Mamografía disminuye la mortalidad en cáncer de mama y el riesgo de cáncer de tiroides

Mammography reduces mortality in breast cancer and the risk of Thyroid Cancer

Authors

  • Douglas Humberto Barros Bravo
  • Verónica Vega Martínez
  • Karina Terán Quelal
  • David Vallejo Terán
  • Mavelin Bonilla Morales

Keywords:

Mammography, breast cancer, thyroid, mortality, thyroid, mortality, detection, radiation

Abstract

This is a bibliographic descriptive review article, the main objective is make aware to the population, doctors and technicians, about the utility of the mammography to reduce breast cancer, and disclosing their null relationship whit the development of thyroid cancer.
It has been collected bibliographic information that has as general objectives:
• Review the international medical literature to know the influence of the mammography in the reduction of the decreased mortality and the relationship of radiation exposure whit the development of thyroid cancer.
• Establish the difference between conventional and digital mammography.
• Define the need of thyroid cervical plumb protection.
• Evidence that the mammography is a reliable screening test that brings more benefits than risks.

Downloads

Download data is not yet available.

References

Cancer Mondial, International Agency for Research on Cancer, IARC, http://www-dep.iarc.fr

Peto R, Boreham J, Clarke M, Davies C, and Beral V, UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000, 355: 1822

Levi F, Bosetti C, Lucchini F, Negri E, and La Vecchia C, Monitoring the decrease in breast cancer mortality in Europe. Eur. J. Cancer Prevention 2005, 14(6): 497-502

Buzzi Alfredo. La mamografía y el riesgo de cáncer de tiroides. Rev. argent. radiol. [Internet]. 2012 Jun [citado 2016 Abr 21] ; 76( 2 ): 143-144. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1852-9992201.

Cáncer de mama en Argentina: organización, cobertura y calidad de las acciones de prevención y control. Informe final julio de 2010: diagnóstico de situación del Programa Nacional y Programas Provinciales, María Viniegra, Melisa Paolino y Silvina Arrossi, 1ª ed., Buenos Aires, Organización Panamericana de la Salud (OPS), 2010

Hendrick RE, Pisano ED, Averbukh A, et al. Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial. AJR Am J Roentgenol 2010; 194:362-9

International Commission on Radiological Protection. ICRP Publication 103: the 2007 recommendations of the International Commission on Radiological Protection. New York: Published for the International Commission on Radiological Protection by Pergamon Press; 2007.

Salud y Medicinas.com.mx [sede Web]. México, D.F.: Editorial Multicolor, S.A. de C.V.; 2012 [consultado abril 2016] Cáncer de tiroides, ¿por el uso de rayos X?. Disponible en: http://www.saludymedicinas.com.mx/centros-e-salud/saludfemenina/articu.

Sechopoulos I, Suryanarayanan A, Vedantham S, D’Orsi CJ, Karellas A. Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology 2008; 246:434-43

National Research Council (U.S.); Committee to Assess Health Risks From Exposure to Low Level of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2 Washington: National Academies Press; 2006.

Published

2020-06-30

How to Cite

1.
Barros Bravo DH, Vega Martínez V, Terán Quelal K, Vallejo Terán D, Bonilla Morales M. Mamografía disminuye la mortalidad en cáncer de mama y el riesgo de cáncer de tiroides: Mammography reduces mortality in breast cancer and the risk of Thyroid Cancer. lauinvestiga [Internet]. 2020 Jun. 30 [cited 2024 May 12];7(1):8 – 14. Available from: http://revistasojs.utn.edu.ec/index.php/lauinvestiga/article/view/483

Issue

Section

Original articles

Most read articles by the same author(s)

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.